454 related articles for article (PubMed ID: 16862606)
1. Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.
Mohamed S; Bondi MW; Kasckow JW; Golshan S; Jeste DV
Int J Geriatr Psychiatry; 2006 Aug; 21(8):711-8. PubMed ID: 16862606
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients.
Bowie CR; Serper MR; Riggio S; Harvey PD
Schizophr Bull; 2005 Jan; 31(1):175-82. PubMed ID: 15888435
[TBL] [Abstract][Full Text] [Related]
4. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.
Fan X; Henderson DC; Nguyen DD; Cather C; Freudenreich O; Evins AE; Borba CP; Goff DC
Psychiatry Res; 2008 May; 159(1-2):140-6. PubMed ID: 18423611
[TBL] [Abstract][Full Text] [Related]
5. Is quality of life associated with cognitive impairment in schizophrenia?
Alptekin K; Akvardar Y; Kivircik Akdede BB; Dumlu K; Işik D; Pirinçci F; Yahssin S; Kitiş A
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):239-44. PubMed ID: 15694230
[TBL] [Abstract][Full Text] [Related]
6. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics.
Sota TL; Heinrichs RW
Compr Psychiatry; 2004; 45(5):415-21. PubMed ID: 15332206
[TBL] [Abstract][Full Text] [Related]
7. Substance abuse and cognitive functioning in schizophrenia.
Addington J; Addington D
J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.
Herman M
Int J Ment Health Nurs; 2004 Dec; 13(4):282-91. PubMed ID: 15660598
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
Woon PS; Chia MY; Chan WY; Sim K
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):463-8. PubMed ID: 20109511
[TBL] [Abstract][Full Text] [Related]
11. Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism.
Allen DN; Goldstein G; Forman SD; Keshavan MS; van Kammen DP; Sanders RD
Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jul; 13(3):184-7. PubMed ID: 10910089
[TBL] [Abstract][Full Text] [Related]
12. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
Savilla K; Kettler L; Galletly C
Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
[TBL] [Abstract][Full Text] [Related]
15. Cognitive functioning related to quality of life in schizophrenia.
Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266
[TBL] [Abstract][Full Text] [Related]
16. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
17. Reexamination of the characteristics of the deficit schizophrenia patients.
Tiryaki A; Yazici MK; Anil AE; Kabakçi E; Karaağaoğlu E; Göğüş A
Eur Arch Psychiatry Clin Neurosci; 2003 Oct; 253(5):221-7. PubMed ID: 14504990
[TBL] [Abstract][Full Text] [Related]
18. Correlates of health-related quality of well-being in older patients with schizophrenia.
Mittal D; Davis CE; Depp C; Pyne JM; Golshan S; Patterson TL; Jeste DV
J Nerv Ment Dis; 2006 May; 194(5):335-40. PubMed ID: 16699382
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
Brissos S; Dias VV; Carita AI; Martinez-Arán A
Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
[TBL] [Abstract][Full Text] [Related]
20. The neuropsychological consequences of abstinence among older alcoholics: a cross-sectional study.
Munro CA; Saxton J; Butters MA
Alcohol Clin Exp Res; 2000 Oct; 24(10):1510-6. PubMed ID: 11045859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
